Arkansas Insurance Department interior office sign
The Arkansas insurance commissioner and 340B covered entities told a federal district judge that a state law requiring drug makers to honor 340B contract pharmacy arrangements does not conflict with federal laws.

Arkansas’ Novel 340B Contract Pharmacy Law Doesn’t Conflict with Federal Law, State Officials Tell Court

Arkansas’s first-of-its-kind law requiring drug makers to honor 340B pricing when covered entities use contract pharmacies to dispense 340B drugs is not preempted by the federal 340B statute since the state law applies only to the acquisition and delivery of 340B drugs, not to pricing, said Arkansas state officials in a responsive brief filed in Arkansas district court earlier this month.

The Sept. 8 filing responded to a lawsuit filed by drug industry trade group Pharmaceutical Research and Manufacturers of America, challenging an Arkansas law passed in May 2021 that explicitly prohibits drug manufacturers from denying 340B pricing or restricting access to drugs when covered entities contract with pharmacies to dispense 340B drugs to patients.

Arkansas’s first-of-its-kind law requiring drug makers to honor 340B pricing when covered entities use contract pharmacies to dispense 340B drugs is not preempted by the federal 340B statute since the state law applies only to the acquisition and delivery of 340B drugs, not to pricing, said Arkansas state officials in a responsive brief filed in Arkansas district court earlier this month.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer